Skip to content
MedTech Companies
-
Abbott secures CE mark for world’s first glucose-ketone wearable
The approval strengthens Abbott’s position in the continuous glucose monitoring (CGM) market and expands its diagnostic capabilities beyond glucose-only tracking, which has traditionally defined wearable diabetes management tools.